8-K ·Filed Feb 26, 2026

TFX

TELEFLEX INC
MIXED
Impact 7/10
Horizonmonths Processed7mo ago SEC0000096943-26-000011
Killer combo: Earnings + restructuring announcement
Actionable Insight ◆ Mixed

The stock may react negatively to the decline in adjusted EPS guidance despite strong 2025 results, as the market will focus on the $90 million in stranded costs impacting 2026. However, the long-term outlook appears positive with the company planning to use $1.8 billion in divestiture proceeds for debt reduction and share repurchases, which should benefit shareholders in 2027 and beyond.

DirectionMixed
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
TFX ▲ +11.41% at T+60d
NEUTRAL call ✓ call won +11.41% · α vs SPY +3.66% · entry $118.39 → $131.90
Entry anchored
Feb 25, 03:59 PM ET
via exchange tick
T+1d
+2.38%
call +2.38% · α +2.83%
$121.21
settled 7mo ago
T+5d
-1.39%
call -1.39% · α -0.26%
$116.75
settled 7mo ago
T+20d
-6.77%
call -6.77% · α -0.36%
$110.38
settled 6mo ago
T+60d
+11.41%
call +11.41% · α +3.66%
$131.90
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Teleflex reported strong 2025 financial results with GAAP revenue up 17.2% and adjusted EPS up 8.7% year-over-year. The company announced a restructuring plan to mitigate $48-52 million in annual stranded costs from its strategic divestitures and provided 2026 guidance calling for mid-single-digit pro forma adjusted constant currency revenue growth of 4.5%-5.5% and adjusted EPS of $6.25-$6.55, which includes the full impact of stranded costs.

Key Financial Metrics

Revenue
$2.0B
+17.2% YoY
Adj. EPS
$6.98
GAAP: $1.31
Guidance
$2.28B-$2.30B
maintained
Gross Margin
56.2%

Key Facts

  • 2025 GAAP revenue from continuing operations was $1,992.7 million, up 17.2% YoY
  • 2025 adjusted diluted EPS from continuing operations was $6.98, up 8.7% YoY
  • 2026 guidance includes pro forma adjusted constant currency revenue growth of 4.5%-5.5%
  • 2026 adjusted EPS guidance is $6.25-$6.55, representing a 6.2%-10.5% decline from 2025
  • Company announced restructuring plan targeting $48-52 million in annual pre-tax savings
  • Strategic divestitures expected to close in second half of 2026 with $1.8 billion in after-tax proceeds

Financial Impact

2026 adjusted EPS guidance of $6.25-$6.55 represents a 6.2%-10.5% decline from 2025's $6.98, primarily due to $90 million in stranded costs from divestitures

revenueepsmarginsdilution

Segment Breakdown

SegmentRevenueGrowth
Vascular$917.7M+2.4%
Interventional$647.8M+8.1%
Surgical$418.2M+3.2%

Risk Factors

  • Execution risk in completing the strategic divestitures in second half of 2026
  • Potential failure to realize the expected $48-52 million in annual cost savings from restructuring
  • The $90 million in stranded costs could pressure margins more than anticipated in 2026

Market Snapshot

Exchange
NYSE

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000096943-26-000011
Exhibit: exhibit992to2-26x2026re2.htm0000096943-26-000011
Document: tfx-20260223.htm0000096943-26-000011
Document: 0000096943-26-000011-index-headers.html0000096943-26-000011
Document: 0000096943-26-000011-index.html0000096943-26-000011
Document: 0000096943-26-000011.txt0000096943-26-000011
9 reports for TFX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for TFX — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
MIXED ★ 6/10
$138.89 $139.96▲ +0.77%▲ +0.17%$124.12 (−10.63%)
Jul 2, 2026
13w ago
Court Ruling
BULLISH ★ 6/10
$133.99 $132.30▼ −1.26%▼ −0.85%$124.12 (−7.37%)
Jun 22, 2026
14w ago
Institutional Cluster
MIXED ★ 4/10
$121.67 $134.61▲ +10.64%▲ +10.78%$124.12 (+2.01%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 4/10
$127.87 $130.16▲ +1.79%▲ +1.59%$124.12 (−2.93%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$132.15 $134.04▲ +1.43%▼ −2.19%$124.12 (−6.08%)
Jun 1, 2026
17w ago
8-K
NEUTRAL ★ 4/10
$127.31 $127.49▲ +0.14%▲ +2.45%$124.12 (−2.51%)
May 27, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$128.90 $127.79▼ −0.86%▲ +1.83%$124.12 (−3.71%)
May 7, 2026
21w ago
8-K
MIXED ★ 6/10
$131.59 $128.56▼ −2.31%▼ −5.44%$124.12 (−5.68%)
Feb 26, 2026
31w ago
8-K
MIXED ★ 7/10
$118.39 $110.38▼ −6.77%▼ −0.36%$124.12 (+4.84%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 5m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access